What Are the Signs of Liver Damage From TB Medication?
At a Glance
Signs of liver damage from tuberculosis medication include jaundice (yellow eyes or skin), dark tea-colored urine, pale stools, persistent nausea, and severe upper right abdominal pain. If you experience these symptoms, stop taking your medication and seek medical care immediately.
In this answer
4 sections
Tuberculosis medications—specifically the commonly prescribed combination of isoniazid, rifampin, and pyrazinamide—are highly effective but can be hard on the liver [1][2]. (You may also be taking a fourth medication, ethambutol, but isoniazid, rifampin, and pyrazinamide are the ones most likely to affect the liver). This side effect is known as drug-induced liver injury (DILI). While your healthcare team will monitor your liver through regular blood tests, it is critical that you know the physical signs of liver distress [3]. The most important symptoms to watch for are jaundice (yellowing of the skin or eyes), dark, tea-colored urine, persistent nausea, and severe upper right abdominal pain [4][5]. If you experience any of these severe symptoms, stop taking your tuberculosis medications immediately and seek urgent medical care [3][6].
Early Warning Signs
Liver damage does not always start with obvious signs like jaundice. Often, the earliest indicators feel like a mild flu or general stomach upset [4][7]. Because these symptoms are vague, they are easy to brush off, but they warrant a call to your doctor:
- Persistent Nausea and Vomiting: Feeling sick to your stomach that does not go away.
- Loss of Appetite: A sudden, unexplained loss of interest in eating.
- Unexplained Fatigue: Feeling unusually exhausted or weak, even when resting.
Clear Red Flags of Liver Injury
As liver inflammation progresses, the liver becomes unable to properly filter waste products (like bilirubin) from your blood [5]. This leads to more specific, noticeable signs. If you notice any of the following, do not take your next dose of medication. Stop your pills and contact your healthcare provider immediately:
- Jaundice: A noticeable yellowing of the whites of your eyes or your skin [8].
- Dark Urine: Urine that appears dark brown, similar to the color of tea or cola [5].
- Pale or Clay-Colored Stools: When the liver cannot process bile properly, your stool may become unusually light in color [8].
- Severe Abdominal Pain: A dull, aching, or sharp pain in the upper right side of your stomach, which is where your liver is located [4].
- Intense Itching: Severe itching all over the body without an accompanying rash [5][9].
It is important not to hide these symptoms out of fear that your tuberculosis will go untreated. If your liver shows signs of distress, doctors can adjust your medication regimen to keep you safe while still treating the infection [6].
When Is the Risk Highest?
While liver damage can occur at any point during your tuberculosis treatment, the highest risk typically happens during the first one to two months of taking the medications [10]. This period is when you should be most vigilant about checking for symptoms.
Who Is Most at Risk?
Some people have a higher chance of developing liver problems from tuberculosis medications. Factors that increase your risk include:
- Pre-existing Liver Disease: Conditions like hepatitis B, hepatitis C, or fatty liver disease [11].
- High Alcohol Intake: Drinking alcohol forces your liver to work harder and dramatically increases the risk of damage when combined with these medications [11].
- Other Medications and Supplements: Over-the-counter pain relievers (like acetaminophen), herbal remedies, and other prescription medications can compound the strain on your liver [11]. Always clear new pills with your doctor.
- Genetics: Some individuals process medications more slowly (often called “slow acetylators”), which causes the drugs to stay in the liver longer [12][13].
- Age and Gender: Older age and being female are often associated with a higher likelihood of liver toxicity [11].
Your doctor monitors your bloodwork to catch these issues early, but paying attention to how your body feels is an essential part of keeping you safe during treatment [14][3].
Common questions in this guide
What are the early warning signs of liver damage from TB meds?
Why does my urine look dark while taking tuberculosis medication?
When am I at the highest risk for liver damage during TB treatment?
Should I stop taking my TB medication if my stomach hurts?
Does drinking alcohol increase my risk of liver damage while on TB treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific blood tests will we use to monitor my liver function, and how often will I need them?
- 2.If I start feeling nauseous, how can I tell the difference between a normal stomach upset and an early warning sign of liver damage?
- 3.Who should I call after hours or on weekends if I notice a red flag symptom like dark urine or yellow eyes?
- 4.Are there any over-the-counter medications, vitamins, or herbal supplements I should completely avoid while on this therapy?
- 5.If my liver does show signs of distress, what is the backup plan for adjusting my tuberculosis treatment?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms.
Ezhilarasan D
Drug metabolism reviews 2023; (55(3)):239-253 doi:10.1080/03602532.2023.2215478.
PMID: 37218081 - 2
Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review.
Zhuang X, Li L, Liu T, et al.
Frontiers in pharmacology 2022; (13()):1037814 doi:10.3389/fphar.2022.1037814.
PMID: 36299895 - 3
Incidence and risk factors of abnormal liver function and anti-tuberculosis drug-induced liver injury: a multicenter retrospective study involving 482 chinese pediatric tuberculosis patients.
Zhou Y, Wang M, Xu H, et al.
Annals of medicine 2025; (57(1)):2546701 doi:10.1080/07853890.2025.2546701.
PMID: 41219178 - 4
Drug-induced liver injury. Part II: Late complications and hepatotoxicity monitoring.
Kozielewicz DM, Stalke P
Clinical and experimental hepatology 2025; (11(2)):89-96 doi:10.5114/ceh.2025.151868.
PMID: 40904658 - 5
Bile Duct Injury due to Drug Induced Liver Injury.
Grewal P, Ahmad J
Current hepatology reports 2019; (18(3)):269-273 doi:10.1007/s11901-019-00474-0.
PMID: 33134030 - 6
Predicting Antituberculosis Drug-Induced Liver Injury Using an Interpretable Machine Learning Method: Model Development and Validation Study.
Zhong T, Zhuang Z, Dong X, et al.
JMIR medical informatics 2021; (9(7)):e29226 doi:10.2196/29226.
PMID: 34283036 - 7
Clinical management of patients with drug-induced liver injury (DILI).
Björnsson ES
United European gastroenterology journal 2021; (9(7)):781-786 doi:10.1002/ueg2.12113.
PMID: 35084797 - 8
Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review.
Gayam V, Mandal AK, Khalid M, et al.
Journal of community hospital internal medicine perspectives 2018; (8(5)):311-314 doi:10.1080/20009666.2018.1514933.
PMID: 30356994 - 9
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
Medina-Cáliz I, Sanabria-Cabrera J, Villanueva-Paz M, et al.
Archives of toxicology 2024; (98(1)):303-325 doi:10.1007/s00204-023-03630-0.
PMID: 38051367 - 10
Early monitoring for detection of antituberculous drug-induced hepatotoxicity.
Lee CM, Lee SS, Lee JM, et al.
The Korean journal of internal medicine 2016; (31(1)):65-72 doi:10.3904/kjim.2016.31.1.65.
PMID: 26767859 - 11
Magnitude, outcome, and associated factors of anti-tuberculosis drug-induced hepatitis among tuberculosis patients in a tertiary hospital in North Ethiopia: A cross-sectional study.
Gezahegn LK, Argaw E, Assefa B, et al.
PloS one 2020; (15(11)):e0241346 doi:10.1371/journal.pone.0241346.
PMID: 33170847 - 12
N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study.
Cheng F, Jiang XG, Zheng SL, et al.
Frontiers in pharmacology 2023; (14()):1171353 doi:10.3389/fphar.2023.1171353.
PMID: 37719844 - 13
The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis.
Zhang M, Wang S, Wilffert B, et al.
British journal of clinical pharmacology 2018; (84(12)):2747-2760 doi:10.1111/bcp.13722.
PMID: 30047605 - 14
Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury.
Huang D, Peng J, Lei L, et al.
Journal of clinical and translational hepatology 2023; (11(2)):425-432 doi:10.14218/JCTH.2022.00077.
PMID: 36643044
This page provides educational information on identifying potential liver damage from tuberculosis medications. It is not a substitute for professional medical advice; always contact your healthcare provider immediately if you experience potential side effects.
Get notified when new evidence is published on Tuberculosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.